Comparison Between Heart Failure Without Left Ventricular Systolic Dysfunction and Progression to End-Stage in Hypertrophic Cardiomyopathy
Author:
Affiliation:
1. Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center
2. Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
Publisher
Japanese Circulation Society
Link
https://www.jstage.jst.go.jp/article/circj/88/9/88_CJ-24-0049/_pdf
Reference40 articles.
1. 1. Olivotto I, Cecchi F, Poggesi C, Yacoub MH. Patterns of disease progression in hypertrophic cardiomyopathy: An individualized approach to clinical staging. Circ Heart Fail 2012; 5: 535–546.
2. 2. Marstrand P, Han L, Day SM, Olivotto I, Ashley EA, Michels M, et al. Hypertrophic cardiomyopathy with left ventricular systolic dysfunction: Insights from the SHaRe Registry. Circulation 2020; 141: 1371–1383.
3. 3. Rowin EJ, Maron BJ, Carrick RT, Patel PP, Koethe B, Wells S, et al. Outcomes in patients with hypertrophic cardiomyopathy and left ventricular systolic dysfunction. J Am Coll Cardiol 2020; 75: 3033–3043.
4. 4. Yagi N, Seguchi O, Mochizuki H, Kuroda K, Nakajima S, Watanabe T, et al. Implantation of ventricular assist devices in hypertrophic cardiomyopathy with left ventricular systolic dysfunction. ESC Heart Fail 2021; 8: 5513–5522.
5. 5. Liang LW, Lumish HS, Sewanan LR, Shimada YJ, Maurer MS, Weiner SD, et al. Advanced heart failure therapies for hypertrophic cardiomyopathy: State-of-the-art review and an updated analysis from UNOS. JACC Heart Fail 2023; 11: 1473–1480.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3